SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-029127
Filing Date
2018-11-13
Accepted
2018-11-13 07:42:26
Documents
45
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q apls-10q_20180930.htm 10-Q 1414724
2 EX-31.1 apls-ex311_10.htm EX-31.1 16663
3 EX-31.2 apls-ex312_6.htm EX-31.2 16144
4 EX-32.1 apls-ex321_11.htm EX-32.1 8578
5 EX-32.2 apls-ex322_8.htm EX-32.2 8585
  Complete submission text file 0001564590-18-029127.txt   2908317

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT apls-20180930.xml EX-101.INS 240986
7 XBRL TAXONOMY EXTENSION SCHEMA apls-20180930.xsd EX-101.SCH 26970
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apls-20180930_cal.xml EX-101.CAL 29330
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apls-20180930_def.xml EX-101.DEF 69657
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE apls-20180930_lab.xml EX-101.LAB 190573
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apls-20180930_pre.xml EX-101.PRE 136901
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38276 | Film No.: 181175156
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1